Ciprofloxacin
|
Quinolones
- Non fluorinated
quinolones include nalidixic acid; fluorinated quinolones (fluoquinolones)
include norfloxacin, ciprofloxacin, ofloxacin, pefloxacin, sparfloxacin
- Nalidixic acid has been in use for many years, but has limited therapeutic
utility (UTI, GI infections), and bacterial resistance occurs rapidly
- Fluoquinolones, e.g., norfloxacin and ciprofloxacin have broad spectrum
of activity, and relatively infrequent development of resistance
|
Ciprofloxacin-Chemistry
-
Ciprofloxacin is a fluoroquinolone with a fluorine atom at position
6 of the 4-quinolone nucleus. This enhances the antibacterial spectrum
and drug potency - Piperazine group at position 7 results in anti-pseudomonal
activity
|
Mechanism
of Action
- Bactericidal
- Inhibits bacterial DNA gyrase, inhibiting supercoiling of DNA and
interfering with bacterial replication
- Post antibiotic effect
|
Antibacterial
Spectrum
- Similar to
other quinolones (mainly gm -ve bacteria)
- More potent than norfloxacin
Important organisms covered
- E.coli
- Klebsiella pneumoniae
- Proteus mirabilis & vulgaris
- Salmomella typhi, paratyphi & typhimurium
- Shigella,
- Yersinia, enterocolitica
- H. influenzae
- Pseudomonas aeruginosa,
- Campylobacter jejuni
- Neosseria meningitidis & gonorrhoeae
- Serratia marcescens
- Some staphylococci& streptococci
|
Resistance
- Rare
(1 in 107-109)
- Due to chrosomal mutation
- Not plasmid mediated
|
Pharmacokinetics
Absorption
- Well absorbed following oral administration
- Peak levels in 0.5-2.3 hours
- Peak serum conc. 0.76 -1.5 and 1.6 - 2.9 mg/ml after 250 and 500
mg orally respectively
- Food decreases rate but not extent of absorption
|
Pharmacokinetics
(contd.)
Distribution
- Widely distributed in body tissues and fluids after oral/IV administration
- High concentrations in bile, lungs, kidney, gall bladder, uterus,
seminal fluid, prostate, endometrium, fallopian tubes, ovaries
- Effective against intracellular organisms
- Low concentrations in CSF; increased when meninges are inflamed
- Crosses placenta and distributed in milk
|
Pharmacokinetics
(contd.)
Elimination
- Serum half life 3-5 hours
- In renal failure, serum concentration is higher and half life is
prolonged
- Partially metabolised in liver; metabolites have some activity,
though less than the parent drug
- Excreted in urine and faeces
|
Adverse
Effects
- Well
tolerated
- Most frequent effects involve GI tract, CNS and skin
- Effects include nausea, vomiting, diarrhoea, abdominal pain/discomfort,
headache, restlessness and skin rash
|
Precautions
& Contraindications
- Crystalluria
is a rare adverse effect. Adequate fluid intake is advised
- Caution in patients with CNS disorders / predisposition to seizures
because of CNS stimulation with ciprofloxacin. Caution also in patients
on theophylline and caffeine
- Reduce dosage/frequency in serious renal impairment
- Contraindicated in hypersensitivity
- Animal studies showed damage to articular cartilage; avoid in children
and pregnancy
|
Drug Interactions
- Antacids
containing magnesium, aluminium or calcium decrease absorption
- Probenecid decreases renal excretion
- Theophylline levels are raised
|
Dosage
250 - 750 mg 12 hourly,depending upon severity
In
renal impairment
Creatinine
Clearance |
Dosage
|
>
50 ml/min
30-50 ml/min
5-29 ml/min
Patients on dialysis |
usual
dosage
250-500
mg 12 hrly
250-500 mg 18 hrly
250-500 mg 24 hrly(after dialysis) |
|
Clinical
Uses
1. Urinary
Tract Infections (UTI)
- Covers E.coli, Klebsiella, Proteus, Pseudomonas, Serratia, staphylococci
and some streptococci
- Useful for uncomplicated or complicated infections
- Single dose therapy may be effective in uncomplicated infections
- Good concentration in prostate; useful in prostatitis
|
2.
Lower Respiratory Infections
- Covers H.influenzae, Klebsiella, Proteus, Pseudomonas, M.catarrhalis,
staphylococci and some streptococci
- Useful for bronchitis, bronchiectasis, lung abscess, pneumonia
- Employed for Ps. aeruginosa infections in patients with cystic fibrosis
|
3.
Skin & Soft Tissue Infections
- Effective in cellulitis, abscesses and infected ulcers, burns or
wounds
- Useful for hospital acquired decubitus ulcers (bed sores)
4.
Bone & Joint Infections
- Especially if caused by gm -ve organisms
|
5. Gastrointestinal
(GI) Infections
- Covers E.coli, Shigella, Salmonella, Aeromonas, Vibrio, Yersinia
enterocolitica and Campylobacter.
- A drug of choice for infectious diarrhoea
- Poor coverage of anaerobes; does not disturb normal anaerobic bowel
flora
6. Salmonella
infections
- Effective in typhoid and paratyphoid, including chloramphenicol
resistant cases
- Useful in typhoid carriers
- Can be used for S. typhimurium septicaemia and osteomyelitis in
AIDS / immunocompromised patients
|
7.
Gonorrhoea
- Effective against penicillinase producing and non penicillinase
producing N. gonorrhoeae
- Single dose (500 mg) therapy adequate for uncomplicated gonorrhoea
8.
Chancroid
- Covers H. ducreyi.
- 500 mg twice daily for 3 days
|
9. Perioperatively
- Covers Pseudomonas aeruginosa and staphylococci. Useful in preventing
/ treating hospital-acquired infections
10.
Nosocomial Infections
- Covers Pseudomonas aeruginosa and staphylococci. Useful in preventing
/ treating hospital-acquired infections
10.
Other uses
- Eliminates staphylococcal colonisation in seriously ill patients
- Eliminates nasopharyngeal carriage of N. meningitidis
|
Salient
Features
- Broad
spectrum coverage especially gm -ve bacteria
- Oral therapy for Pseudomonas aeruginosa infection
- Effective against bacteria resistant to other important agents e.g.,
penicillins and cephalosporins
- Significant post antibiotic effect
- Bactericidal even in presence of pus
- Resistance is not common
- Effective against intracellular (“resting”) organisms
- Does not disturb normal anaerobic bowel flora
- Wide distribution in the body
- Convenient twice daily dosing
- Effective in GI infections, enteric fever, UTI, gonorrhoea, nosocomial
and other infections
- Well tolerated
|
Advantages
over other agents
Other
fluoroquinolones
- Norfloxacin is poorly distributed in the body and is used in GI
and genitourinary infections only
- Sparfloxacin & Ofloxacin are relatively expensive
- Adverse effects with pefloxacin
|
Penicillins
(e.g., ampicillin, amoxycillin)
- Ampicillin
& Amoxycillin may still be used for ENT / Respiratory infections
- However, resistance due to beta-lactamase production is common;
ciprofloxacin not affected by bacterial beta-lactamases
- Ciprofloxacin has better activity against gm -ve bacteria; hence
preferred for GI infections, enteric fever, UTI
|
Cephalosporins
- Ciprofloxacin
is effective orally, whereas many cephalosporins are given parenterally
- Oral therapy even for Pseudomonal infections
- Compared to oral cephalosporins (e.g., cephalexin, cefadroxil, cefaclor),
ciprofloxacin has better gm -ve coverage
- Ciprofloxacin is not affected by beta-lactamase produced by bacteria
|
Macrolides
- Macrolides
(erythromycin, roxithromycin, azithromycin) are chiefly used for infections
caused by gm +ve bacteria; hence mainly used in RTI, ENT infection
and Skin & soft tissue infection
- Ciprofloxacin has broader coverage and wider applicability
|